hypomagnesemia 英 /'haipə,mæɡnə'si:miə/
释 义 n. （美）低镁症；（尤指牛的）血镁过少
例 句 The incidence of hypomagnesemia was significantly higher in patients with arrhythmias than those without, the percentages of incidence were 83.9 and 26.6 (P<0.001) respectively.在这些心律失常患者中，低镁血症明显多于无心律失常患者，分别占83.9%与26.6%（P<0.001）。
作者： Yael Peled
Another unfavorable post-HT occurrence may be the development of a magnesium deficiency, to which a possible contributory factor is the administration of calcineurin inhibitors (CNIs), which are known to induce magnesium urinary wasting. Moreover, MiR133a-regulated calcineurin-nuclear factor in activated T cells c4 (NFATc4) signialling and DNA methyltransferases-1 (DNMTs-1)-3a is changed in diabetic hearts and has been shown to be associated with a hypertrophic response and cardiac remodeling. Indeed, it has been reported that hypomagnesemia frequently develops within the first few weeks following kidney transplantation, with a nadir in the serum magnesium (s-Mg) level in the second month post-transplantation and persistent hypomagnesemia is invariably accompanied by myocardial magnesium depletion in the transplanted heart. Several studies have indicated that magnesium deficiency is nonetheless a potentially modifiable risk factor for diabetes in both non-transplant patients and in kidney transplant recipients; it is also known that magnesium in the high-normality range is associated with a lower cardiovascular risk and its levels are independently and inversely associated with prediabetes and overt diabetes. The molecular basis for the involvement of magnesium in the pathogenesis of diabetes may lie in its role as a co-factor in several pathways, including glucose transport and insulin sensitivity and secretion. In healthy individuals, binding of insulin to insulin receptor in vitro leads to translocation of magnesium to platelets, leading to reduced platelet aggregation and decreased release of pro-aggregatory agents like thromboxane; this protective effect is lost in diabetics.